News

  • Wave Life Sciences Shares 48-Week Data from FORWARD-53 Trial of WVE-N531 in Duchenne Muscular Dystrophy

    Dear Members of the Duchenne community,We are excited to share positive data following 48 weeks of dosing in the FORWARD-53 clinical trial eval...
  • Duchenne Care Conference 2025

    The World Duchenne Organization is thrilled to announce that registrations are now open for the Duchenne Care Conference 2025. The online confe...
  • Sarepta Therapeutics Shares Safety Update on ELEVIDYS

    CAMBRIDGE, Mass., March 18, 2025 -- Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, share...
  • Dyne Therapeutics Announces New Long-Term Clinical Data

    Dyne Therapeutics Announces New Long-Term Clinical Data from Phase 1/2 DELIVER Trial of DYNE-251 in Duchenne Muscular Dystrophy Demonstrating U...
  • Edgewise Therapeutics Topline results from phase 2 Becker Canyon trial of Sevasemten

     - Trial met primary endpoint of reduction in circulating levels of creatine kinase (CK), a biomarker associated with skeletal muscle damage, i...
  • Update to the Duchenne Community from Percheron Therapeutics on Progress with Avicursen

    Dear Members of the Duchenne Community, Today, Percheron Therapeutics, a public company registered in Australia and focused on developing treat...
  • No Life Insurance Discrimination For Those With a Genetic Condition

    Australian Government bans genetic discrimination in life insurance: A big win for preventive health Following the recommendations of a r...
  • Final Letter for Philips Recall

    Philips after consultation with TGA is conducting an Urgent Product Defect Correction for the Philips BiPAP A40 Pro Ventilator, BiPAP A40 E...
  • Update to Urgent Product Defect Alert TGA Ref RC-2024-RN-00257-1- Philips Ref 2023-CC-SRC-039

    Philips after consultation with TGA is conducting an update to the Urgent Product Defect Alert of Philips BiPAP A30, BiPAP A30 EFL, BiPAP A...
  • Pfizer Phase 2 Daylight Study Update

    DOWNLOAD PDF
  • Pfizer gene therapy clinical trials commence in Australia

    Pfizer gene therapy clinical trials commence in Australia! The first Australian boy has been screened as part of the Pfizer gene therapy clinica...
  • “New Frontiers” Launched

    The long awaited Federal Parliamentary Inquiry report into Approval Process for New Drugs and Novel Technologies has now been released. The reco...